INSIGHTS CENTER

The Synapmed Insights Center offers expert perspectives and strategies to help biopharma and life sciences companies confidently navigate drug and product development and commercialization.

Effect of COVID-19 on Pharmacovigilance & How global Life Science companies can be better prepared during the pandemic

Pharmacovigilance Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. Background: WHO established its Program for International Drug Monitoring in response to the thalidomide disaster detected in 1961 (Many children in the 1960’s were born with Phocomelia as a...

Pharmacovigilance – Should You Outsource?

The law governing pharmacovigilance lay down rigid details on what pharmaceutical firms must do in the event of analysing a serious adverse event and indeed what constitutes a serios adverse event. With these major demands on pharmaceutical firms, its essential for them to set up a right pharmacovigilance system and this might cause a various...

WHAT IS THE RIGHT OUTSOURCING STRATEGY FOR YOUR COMPANY? Not One Model Fits All

Introduction Pharmacovigilance (PV) is fundamental to the Pharmaceutical and Biotech industries. More now than ever, safety regulations are numerous and complex around the world. Regulatory authorities are requiring more safety documentation and review for product approvals and maintenance of the products license. Safety concerns have prompted global mandates for submitting significantly more product information. There...

Harnessing the power of Artificial Intelligence for KOL Engagement

Recent surveys have shown that pharmaceutical companies and the industry in general is challenged with over 50% failures of new drug launches....

Real World Data (RWD) vs Real World Evidence (RWE)

RWD offers meaningful insight into diverse populations, the amount of data collection would be voluminous in a short span of time. The RWD collected in a post marketing stage can augment the value to the CT Data....

Synapmed Announces Growing Prominence of Adverse Event Signal Detection Platform

NEW YORK, June 20, 2023 /PRNewswire/ — AstaLynx Global is pleased to announce the growing prominence of its proprietary signal detection and management system, ADRium-Signals™. Over the last 12 months, ADRium-Signals has replaced two of the top leading legacy signal detection systems at several midsize pharmaceutical companies. ADRium Signals has been selected by these companies...

Dedicated to youR Projects

No matter the size or scope of your projects, you have a committed partnership team with Synapmed. We’re a team that listens, pays attention to details, and brings smart insights to the table. We do it all so you can solve real problems throughout the product development and commercialization lifecycle.